Torrent Pharma board okays hiking borrowing limit to Rs 15k cr

Torrent Pharmaceuticals today said its Board has approved a proposal to enhance borrowing limits from Rs 10,000 crore to Rs 15,000 crore.

As per a BSE filing, the Board also approved "issuance of unsecured/secured redeemable non-convertible debentures/bonds by way of private placement for an amount not exceeding Rs 12,500 crore".

The Board also cleared a proposal for issuance of equity shares including convertible bonds/debentures through qualified institutional placement (QIP) and or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore, the company said in the filing.

The drug firm however did not mention what it intends to do with the proposed fundraising.

Shares of Torrent Pharmaceuticals were today trading at Rs 1,433.10 per scrip on BSE, down 1.44 per cent from the previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel